C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated
